sigma特约代理商|E1388-25UG β-Endoth

Vascular Endothelial Growth Factor Expression in Non-Small Cell Lung Cancer

Lung cancer is the most common cause of cancer-related death in the western world. Of patients with lung cancer, in the region of 90% are either current or ex-cigarette smokers. Non-small cell lung cancer (NSCLC) accounts for approx 80

In Vivo Method for Establishing Synergy Between Antibodies to Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor-2

to establish that antibodies targeting the epidermal growth factor receptor and vascular endothelial growth factor receptor-2 are synergistic with regard to antitumor effects, in a BxPC-3 subcutaneous xenograft model for pancreatic cancer.

Secretion of Recombinant Human Insulin-Like Growth Factor I (IGF-I)

The development of efficient recombinant protein production processes can be a critical factor in whether or not a pharmaceutical therapeutic protein can enter human clinical trials and ultimately the marketplace. This is especially true